Health secretary Robert F. Kennedy Jr. announced a new effort to improve autism diagnoses, arguing that the current system is outdated, too time-intensive, and too dependent on professionals who are in short supply.
The initiative will be administered by the Advanced Research Projects Agency for Health and calls for organizations to submit “solutions” using tools and technologies that would both speed up assessments and improve autistic people’s quality of life. The announcement did not include financial details for the grants.
Kennedy presented the effort during a keynote address at a conference for Children’s Health Defense, the anti-vaccine organization he previously led. He said the goal is not only to describe autism and manage its consequences, but also to ask what drives different forms of autism, why developmental trajectories differ, why some children regress, and which interventions work for them.
Why this matters now
The program targets a real bottleneck in care. STAT noted that wait times for autism assessments can stretch for months or even years as prevalence has increased in recent decades. At the same time, autism care is facing other pressure, with health insurers pulling back from covering the main therapy used to treat kids after the field was shaken by allegations of fraud.
That creates an opening for a federal effort focused on better diagnostics and support tools. Helen Tager-Flusberg, director of the Center for Autism Research Excellence at Boston University, said in a text that it is exciting ARPA-H is focusing on autism and that exploring how technology can transform aspects of diagnosis, interventions, and support is timely. She added that she hoped the review process would lead to an unbiased selection of projects.
The signal for policy and research strategy is that the administration is trying to use ARPA-H as a delivery mechanism for applied autism work rather than relying only on conventional grantmaking. But the absence of funding detail leaves the scale of that commitment unclear.
The credibility problem
The announcement also arrives with a substantial political and scientific overhang. STAT reported that many in the autism community have had to contend with Kennedy’s repeated use of dehumanizing language; during the same keynote, he called autistic kids “damaged.” The article also said he has continued to insist that autism is correlated with vaccines, though there is no scientific evidence for that link.
Kennedy and President Trump have also asserted, without evidence, that autism is connected with Tylenol use during pregnancy. Those claims help explain why many autism researchers have been wary of the federal investigations of autism launched by Kennedy even as some remain cautiously optimistic about other federally backed work in the field.
STAT pointed to the Autism Data Science Initiative, which awarded $50 million to 13 projects through the National Institutes of Health in June. It also described SPECTRA — Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency — as a bet that better understanding of interactions among genetic, environmental, microbiome, and other factors could advance the field. The new ARPA-H effort will be overseen by Program Manager Russell Shilling, who has two kids with autism and previously sat on the Medical and Science Advisory Committee at Autism Speaks.
